Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2025
Association Recherche biomédicale et Diagnostic from Sint-Lambrechts-Woluwe, company number BE0416287871, closed financial year 2025 with a result of € 651,199 after tax. For that financial year Association Recherche biomédicale et Diagnostic recorded a gross margin of € -12,419 and equity of € 3.7 million. Compared with financial year 2024, the result moved from € 580,105 to € 651,199. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 29, 2026.
€ 3.7 million
▲ 22% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 651,199
▲ 12% vs 2024
Profit after tax over the fiscal year.
€ 1.1 million
▲ 56% vs 2024
Cash and bank balances on the last day of the fiscal year.
People and assets in 2025
€ 127
▼ 85% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 521
▼ 7% vs 2024
Supplier invoices still open on the last day of the fiscal year.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € -293,151 | € -316,000 | € -234,134 | € -12,419 | ▲ € 221,716 |
| Profit after taxes | € -439,591 | € -288,236 | € 580,105 | € 651,199 | ▲ 12% |
| Equity | € 2,727,450 | € 2,439,214 | € 3,019,319 | € 3,670,518 | ▲ 22% |
| Total debts | € 561 | € 1,287 | € 561 | € 521 | ▼ 7% |
| Cash | € 31,796 | € 52,396 | € 676,561 | € 1,053,245 | ▲ 56% |
| Retained profit | € 2,727,450 | € 2,439,214 | € 3,019,319 | € 3,670,518 | ▲ 22% |
| Balance sheet total | € 2,728,011 | € 2,440,501 | € 3,019,880 | € 3,671,039 | ▲ 22% |
Key figures of Association Recherche biomédicale et Diagnostic, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Association Recherche biomédicale et Diagnostic?
What happened at Association Recherche biomédicale et Diagnostic in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 651,199 (▲ 12% vs 2024). Source: NBB ↗
- Christophe Erneux became a director. NBB
- Gilbert Vassart became a director. NBB
- Sabine Costaglioia became a director. NBB
- Marc Parmentier became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 439,591 loss in 2022 to € 651,199 profit in 2025.
Paid € 32,583 in corporate taxes since 2022.
Best year ever: 2025, with € 651,199 profit.
A new publication or filing at Association Recherche biomédicale et Diagnostic? We notify you, reason included.
Follow Association Recherche biomédicale et DiagnosticDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Association Recherche biomédicale et Diagnostic are Gilbert Vassart, Sabine Costaglioia, Christophe Erneux and Marc Parmentier. Gilbert Vassart is also behind Applications biomédicales de la Biologie moléculaire. Marc Parmentier is also behind Applications biomédicales de la Biologie moléculaire and CHEMCOM.
Directors
According to the 2025 annual accounts
Gilbert Vassart
(Autre fonction), Director
Also active at: Applications biomédicales de la Biologie moléculaire
since 2020
Sabine Costaglioia
Director
since 2020
Christophe Erneux
Director
since 2023
Marc Parmentier
Director
Also active at: Applications biomédicales de la Biologie moléculaire, CHEMCOM
since 2020
Establishments
Establishment units
Physical locations of this company
Julilaan 8
1200 Sint-Lambrechts-Woluwe
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0416.287.871
- VAT number
- BE 0416.287.871
- Registered office
- Julilaan 8, 1200 Sint-Lambrechts-Woluwe
- Names & denominations
- Association Recherche biomédicale et Diagnostic · A.R.B.D.
- Enterprise type
- Rechtspersoon
- Legal form
- Non-profit association
- Legal situation
- Normale toestand
- Start date
- 5 May 1976
- Peppol
- Not registered